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1. INTRODUCTION 
 
 2 
 
1.1 Etiology 
Sepsis is a severe clinical condition of the body in response to an infection (1). 
Before the year of 2016, the diagnosis of sepsis was made in a patient with systemic 
inflammatory response syndrome (SIRS) resulting from an infection. 
SIRS is defined by the presence of 2 or more of the following criteria in a patient;  
• temperature of above 38°C or below 36°C,  
• heart rate of above 90 beats per minute, 
• respiratory rate of >20 breaths per minute, 
• PaCO2 of below 32 mmHg  
• white blood cell count of above 12 x 109 or below 4 x 109 (2,3) 
This definition has since been revised in the Third International Consensus 
Definitions for Sepsis and Septic Shock (Sepsis-3) (4). Before this revision the definition of 
sepsis was concentrated on SIRS reaction to an infection (5-8), these criteria can still aid in 
identifying patients with sepsis. The revised definition of sepsis states that sepsis is “a life-
threatening organ dysfunction caused by a dysregulated response to infection.”(4,9-11). 
Instead of the before used SIRS criteria the definition of sepsis now focuses on the sequential 
organ failure assessment (SOFA), where sepsis is diagnosed in a patient with an increase of 
the score by 2 or more (4). 
Additionally, septic shock has also been defined in the Sepsis-3 campaign stating that 
shock as a result of sepsis, in which, great circulatory, metabolic and cellular abnormalities 
are associated with a higher risk of mortality compared with sepsis alone (4,9). 
The etiology of sepsis is generally associated with further conditions such as 
perforation, compromise, or rupture of an intra-abdominal or pelvic structure (12). Sepsis may 
also be a consequence of direct introduction through an intravenous infusion. 
In the US a study from 1979-2000 showed that the most prevalent isolated pathogens 
were gram-positive bacteria Streptococcus pneumoniae and Staphylococcus aureus and the 
gram-negative bacteria Escherichia coli, Klebsiella spp., and Pseudomonas aeruginosa 
(13,14).  With the most common sites of infection being lungs or abdomen (15,16). 
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1.2 Epidemiology 
As the definition of sepsis and septic shock was changed recently the epidemiology 
can be hard to evaluate (17). Shankar et al. showed that with the new sepsis-3 definition “The 
extrapolated population incidence of Sepsis-3 sepsis and Sepsis-3 septic shock was 101.8 and 
19.3 per 100 000 person-years, respectively, in 2015” (17), the study was carried out in 
England.  
In Croatia there are not a lot of studies regarding epidemiology of sepsis and septic 
shock especially with the new definition in mind. The studies done are with the old definition 
and results showed an estimated annual incidence of sepsis in Croatia is 0.06% of the 
population in 2005 (18). 
The incidence of sepsis around Europe is approximately 30% with different numbers 
between countries (19)The incidence seems to be rising which probably can be attributed to 
an aging population. The mortality of patients with sepsis is very high and is shown to be 
around 50% (19,20).  
 
1.3 Pathogenesis 
The revised sepsis definition states that sepsis is a severe clinical condition of the 
body in response to an infection (3). The organ dysfunction is characterized by an increase of 
the SOFA score of 2 or more from 0, or the patients baseline. The SOFA score system 
considers the function of respiration, coagulation, liver, cardiovascular, central nervous 
system and renal (4).  
Further, septic shock is defined as “a subset of sepsis in which particularly profound 
circulatory, cellular, and metabolic abnormalities are associated with a greater risk of 
mortality than with sepsis alone.” (4) Patients with septic shock are identified as those who 
require vasopressors to maintain a mean arterial pressure of 65 mmHg or more and with a 
serum lactate level of more than 2 mmol/L (4).  
Sepsis activates both pro- and anti-inflammatory processes (4,21), usually seen as an 
early hyper-inflammatory phase over a few days and then a more extended 
immunosuppressive phase (21,22).  
Septic patients recurrently manifest disseminated intravascular coagulation (DIC) 
(2), they show an alteration of all three of Virchow’s classic triad, changes in coagulability, 
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endothelial cell injury, and abnormal blood flow and thus blood flow to vital organs is 
reduced. (2). 
Apart from the pro- inflammatory and anti-inflammatory processes seen in sepsis, 
major changes in nonimmunologic pathways such as cardiovascular, neuronal, autonomic, 
hormonal, bioenergetic, metabolic and coagulation (4,23), Singer et al. further claims that the 
organ dysfunction seen in the patients is not associated with substantial cell death (4). 
 
1.4 Clinical manifestations 
The clinical manifestations of sepsis and septic shock can be plenty and unspecific. 
Any of the SIRS criteria can be seen in the patient as well as the SOFA score system. These 
include changes in respiration with a decrease of PaO2 pressure, dysfunction of coagulation 
with a decrease in platelet count, liver dysfunction, shown as an increase in bilirubin, as well 
as in AST and ALT levels, cardiovascular dysfunction and hypotension, mental alteration, 
renal dysfunction shown as decrease in urine output and an increase in serum creatinine levels 
(4,24). 
Depending on the origin of infection manifestation of the local infection may also be 
seen, i.e. peritonitis in abdominal origin. 
Septic shock manifests in the patient with sepsis by persistent hypotension even with 
the use of vasopressors (4,25-27). 
 
1.5 Risk factors 
The most obvious risk factor for sepsis and septic shock are infection of any origin. 
The risk of developing sepsis and septic shock is also increased in patients with renal disease, 
indwelling urinary catheter, hematologic malignancy, neutropenia, solid tumors, liver disease, 
pulmonary disease and pneumonia. (28-30). 
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1.6 Diagnostic methods 
 
1.6.1 Definition 
As sepsis has been hard to define (4,6,7),  no clear diagnostic methods or tests exists 
(4,10) and diagnosis is still mostly made up of clinical signs and symptoms.  
The SIRS criteria can still help in aiding with diagnosis of sepsis even though they 
are considered to be nonspecific (4).  
The 2001 task force noted that various examination findings and laboratory test 
results are indicative of organ dysfunction (7) which then can be used in the diagnosis of 
sepsis. These are included in the SOFA scores and so the diagnosis of sepsis is thus made in a 
patient with assumed infection, and an increase in SOFA scores of 2 or more (4,24). 
 
1.6.2 SOFA score 
The diagnostic methods for sepsis and septic shock are thus based on the clinical 
criteria from the task force in 2016 (10,11). With the help of the SOFA score and assumption 
or proof of an infection in a patient, the diagnosis is made (Table 1.). There is no redefinition 
of infection and the suspicion or confirmed case of an infection is enough when there is organ 
dysfunction to diagnose sepsis, as well as the prediction of mortality. Routine microbiologic 
cultures should however be done when there is a suspicion, preferably before the onset of 
antibiotic therapy or within 24 hours (9). 
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Table 1. The SOFA scoring system (4) 
Score 0 1 2 3 4 
 
PaO2/FIO2, 
mmHg (kPa) 
4
400 
(53.3) 
<
400 
(53.33) 
 
<300 (40) 
 
<200 (26.7) with 
respiratory support 
 
<100 (13.3) with 
respiratory support 
 
Platelets, 
x10^3/µL 
>
150 
<
150 
 
<100 
 
<50 
 
<20 
 
Bilirubin 
µmol/L 
<
20 
0
0-32 
 
33-101 
 
102-204 
 
>204 
 
Cardiovascular 
M
MAP 
>70 
mmHg 
M
MAP 
<70 
mmHg 
 
Dopamine <5 
or dobutamine 
(any dose) 
 
Dopamine 5.1-15 or 
epinephrine/norepinephri
ne <0.1 
 
Dopamine >15 or 
epinephrine/norepinephri
ne >0.1 
 
Glasgow coma 
scale score 
1
5 
1
3-14 
 
10-12 
 
6-9 
 
<6 
 
Creatine µmol/L 
<
110 
1
10-170 
 
171-299 
 
300-440 
 
>440 
Urine output, 
mL/day 
   <500 <200 
MAP= mean arterial pressure. Vasoactive drugs (dopamine or norepinephrine) are given as µg/kg/min 
and given for at least 1 hour. 
 
The quick SOFA score (qSOFA) was developed for screening of patients with a 
suspicion of sepsis outside of an ICU setting (Table 2.). Any 2 of the 3 variables is considered 
to be positive and should warrant for further investigation in the patient. The criteria being; 
altered mentation by a Glasgow coma scale (GCS) of less than 13, respiratory rate above 22 
breaths per minute and a systolic blood pressure of 100mmHg or less (4, 31).  
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Table 2. The qSOFA scoring (4) 
qSOFA score  
Respiratory rate >22 per minute 
Altered mental state GCS <13 
Systolic blood pressure <100 mmHg 
 
1.6.3 Definition of septic shock 
Septic shock is a subset of sepsis with profound consequences and increased 
mortality in patients suffering from it (4, 10). When sepsis leads to hypoperfusion and the 
patient needs to be treated by vasopressors, septic shock is diagnosed (32). 
Septic shock is diagnosed in a patient with sepsis where hypotension is persistent 
(mean arterial pressure of below 65mmHg) even with the use of vasopressors and where fluid 
resuscitation has been adequate, as well as an increase in serum lactate. Hyperlactemia is 
defined as a value of more than 2 mmol/L (18 mg/dL) (4, 11). 
The mortality is significantly higher in patients with septic shock, due to the 
unresponsiveness to therapy as well as the multiple organ dysfunction of the patient (1).  
 
1.7 Treatment 
 
1.7.1 Resuscitation 
Early resuscitation of a septic patient, within 6 hours of recognizing sepsis should be 
initiated (9). The initial amount of crystalloids should be aimed at a quantity of 30 ml/Kg, 
given rapidly, within the first 3 hours (higher amounts and quantity may be necessary in some 
patients). Albumin can further be added in those patients who require a continuous and 
substantial amount of crystalloids to maintain adequate mean arterial pressure, even though 
this is a recommendation with weak evidence of effectiveness (9). The fluid challenge should 
be continued as long as an improvement is seen in the patient. After the initial resuscitation, 
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continuous fluid therapy should be given after frequent reassessment of hemodynamic status 
(9). 
 
1.7.2    Antibiotics 
Blood cultures should preferably be taken before initiation of antimicrobial therapy. 
If possible, imaging studies should be performed to confirm site of infection. The initiation of 
antimicrobial therapy should be started within an hour of diagnosis for both sepsis and septic-
shock. The recommendation is to use broad-spectrum therapy with the use of more than one 
antimicrobial therapy to cover as many pathogens as possible until blood cultures are back, 
and a specific antibiotic therapy can be introduced (9). Treatment duration of 7-10 days is 
adequate for both sepsis and septic shock (9). Procalcitonin levels can be used to shorten the 
duration of antibiotics therapy (9).  
 
1.7.3    Vasopressors 
Norepinephrine is recommended as the first vasopressor of choice (9). Vasopressin 
or epinephrine can be added to raise the mean arterial pressure (MAP) to the target value of 
65 mmHg in patients with shock (9). 
The targeted mean arterial pressure in patients with septic shock is, as stated before, 
65 mmHg and should be achieved with a combination of different vasopressors along with 
aggressive fluid therapy. Lactate could be used in guiding of resuscitation and used as a 
marker for hypoperfusion of tissues (9). 
The guidelines states that norepinephrine should be initiated and titrated up to 35-
90µg/min until target MAP is achieved (9). If the target MAP is not achieved by the use of 
norepinephrine, vasopressin should be added. The dose of vasopressin should be up to 0.03 
units/min. In a patient whom the MAP is not satisfactory the third step is to add epinephrine at 
a dose of 20-50 µg/min (9). Phenylephrine should be considered as further therapy if 
epinephrine does not help to reach the target MAP, a dose of up to 200.300 µg/min can be 
given in this case (9).  
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1.7.4   Acute respiratory distress syndrome (ARDS) 
Acute respiratory distress syndrome can be a grave consequence of sepsis and septic 
shock in patients with organ dysfunction of the lungs. The recommended therapy is 
mechanical ventilation. It is then recommended to use a higher PEEP flow rather than a low 
flow but, with a low tidal volume. The recommendation states that a target tidal volume of 
6ml/kg body weight should be achieved (32). It is also recommended to put the patient in a 
prone position rather than supine, when compared to intubated patients in a supine position it 
was noticed that mortality was improved in patients put in a prone position (9), this can, 
however, be hard to achieve in patients who are critically ill. Contrary to the recommendation 
of strong fluid resuscitation, in patients with established ARDS, the guidelines rather 
recommend a conservative fluid therapy as it was shown that in these patients the restricted 
fluid therapy lead to shorter need for mechanical ventilation (9). This can of course only be 
performed in patients with established ARDS and who are not suffering further from septic 
shock.  
 
1.7.5 Other therapies 
Symptomatic therapy should be initiated depending on which organs are affected. In 
patients with renal failure and increased creatine values it is not recommended to start renal 
replacement therapy if the only symptoms are oliguria and increased creatine levels unless 
other definitive indicators of dialysis therapy are present (9). 
 It is strongly recommended to have a strict glucose control of patients with sepsis in 
the intensive care unit with continuous controls of plasma glucose level every 1-2 hours until 
blood glucose is stable and every 4 hours after that. If there are 2 continuous measurements of 
plasma glucose levels above 10mmol/L, insulin therapy should be initiated, with the aim of a 
level below 10mmol/L rather than a target blood glucose below 6.1mmol/L (9).  
When it comes to nutrition in a septic patient, early use of parenteral nutrition is not 
recommended, alone, or in combination with enteral feedings (9). It is rather recommended to 
initiate early enteral feedings when possible. In patients where enteral feeding is not feasible 
the guidelines recommend starting intravenous glucose first and try enteral feedings as soon 
possible over the first 7 days in the critically ill patient. In patients with feeding intolerance, 
vomiting or aspiration of gastric content, the use of prokinetic agents are recommended. If 
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after the initial 7 days enteral feedings cannot be initiated satisfactorily parenteral feedings 
should be considered (9).  
Sepsis is a condition with strong reactions, both with proinflammatory and anti-
inflammatory processes, therapy with agents that decrease cytokines, by the use of a 
hemadsorption device, for blood purification, e.g. cytosorb, can be given as adjunctive 
therapy (33). In patients with septic shock, it was seen that purification with cytosorb reduced 
blood lactate levels as well as stabilized the patients faster (33).  
Corticosteroid therapy in hemodynamically unstable patients are also recommended 
(9,34,35). The dosage recommended is 200mg per day, it was shown that patients treated with 
corticosteroids had a decreased 28-day mortality and that they faster reached hemodynamic 
stability (9,34,35). However, it was shown that administration of corticosteroids in boluses 
lead to hyperglycemia, so strict blood glycemic control needs to be applied, this increase was 
not seen when corticosteroids were given as an infusion (9). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. OBJECTIVES 
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The objective of this study is to determine the incidence of sepsis and septic shock at 
the general Intensive Care Unit of the University Hospital of Split (UHS), Croatia. The study 
will be retrospective and focus on cases between 2015 to the first quarter of 2018.  
Furthermore, we want to know about the most prevalent pathogens causing sepsis, 
age, gender, mortality rate and length of stay of the patients with sepsis and septic shock. 
Additionally, a comparison between the non-septic patients and septic patients will be done, 
in order to compare mortality rates, age, gender and length of stay in the department to 
distinguish differences between these two groups.  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. METHODS 
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3.1 Study type  
The study is a retrospective study that looks at the cases of sepsis and septic shock at 
the Department of Anesthesiology, Resuscitation and Intensive Care of UHS general 
Intensive Care Unit during the period of 2015 up to the first quarter of 2018. The study 
material is gathered by going through patient files during this period and gather information 
about the patients with sepsis and septic shock and further gather information about patient 
age, gender, origin of pathogens if microbiology was managed, mortality and length of stay. 
As well as age, gender, mortality and length of stay of all patients, during the same timeframe, 
who did not have sepsis.  
 
3.2 Ethical issues  
No personal information about patients was gathered, as the information is for 
statistical purposes and no personal information is necessary, thus there is no ethical issues 
with this study. 
  
3.3 Statistical analyses 
The statistical analyses were performed using the statistical software Medcalc for 
Windows [MedCalc Statistical Software version 18.5 (MedCalc Software bvba, Ostend, 
Belgium). 
 
3.4 Data presentation 
The data will be presented in forms of tables, figures as well as in text. The statistical 
tests that will be performed are Chi-square test, Mann-Whitney U-test with a statistical 
significance level of P<0.05. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. RESULTS 
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In total, the general intensive care unit had 1038 patients during the year 2015 to the 
first quarter of 2018, out of which 200 (19.0%) had sepsis. In 2015, 57 patients out of 315 
(18%), 2016, 61 patients out of 330 (18.5%), 2017, 64 patients out of 316 (20%) and during 
the first quarter of 2018, 18 patients out of 77 (23%), patients had sepsis (Figure 1.).  
Median age of patients with sepsis was 66 years (95% CI 63.0 to 67.8). The median 
duration of stay at the intensive care unit for patients with sepsis was 11 days (95% CI 9-13). 
Most patients with sepsis were males, the majority of patients with sepsis developed septic 
shock. Just over half of the patients with sepsis did not survive. Most diagnosis of sepsis was 
confirmed with an hemoculture. Almost half of the patients with confirmed microbiology 
where found to have multiple microorganismal infection (Table 3.). 
The bacteria most commonly seen in hemocultures are coagulase negative 
Staphylococcus species, Acinetobacter baumanii and methicillin resistant Staphylococcus 
epidermidis (MRSE) (Table 5.). 
Median age for patient group without sepsis was 63 years (95% CI 62 to 64). The 
median duration of stay at the intensive care unit for the patient group without sepsis was 4 
days (95% CI 4 to 5). Most patients without sepsis survives their stay at the intensive care unit 
and are transferred to other departments (Table 4.) Most patients in the ICU are males (Table 
4.) 
There is a significant difference between mortality of the patient group with sepsis 
and the patient group without sepsis, P < 0,001. The duration of stay is significantly longer in 
the patient group with sepsis P < 0,001. There is no significant difference between median age 
of the patient group with sepsis compared to the patient group without sepsis, P = 0,286.  
There is no significant difference between genders in the patient group with sepsis 
compared to the patient group without P = 0,346.  
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Table 3. Patients with sepsis 
Variable   n % 
Gender  Male 148 74 
  Female 52 26 
Septic shock  Yes 126 63 
  No 74 37 
Mortality  Deceased 104 52 
  Survived 96 48 
Diagnosis based on hemoculture  Confirmed 152 76 
 Clinical diagnosis 48 24 
Patients with multiple microorganisms confirmed  66 43 
Values represent number and percentage of septic patients for each variable. 
 
 
 
Table 4. Patients without sepsis 
Variable   n % 
Gender  Male 592 70.6 
  Female 246 29,4 
Mortality  Deceased 150 17,9 
  Survived 686 82,1 
Values represent the number and percentage of patients for each variable. 
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Table 5. Microbiological origin from hemoculture of patients with sepsis.  
Microbiology n % 
Coagulase negative Staphylococcus species 55 28% 
Methicillin resistant Staphylococcus epidermidis 48 24% 
Acinetobacter baumanii 39 20% 
Pseudomonas aeruginosa 24 12% 
Klebsiella pneumoniae ESBL+ 19 10% 
Proteus mirabilis 8 4% 
Enterococcus faecalis 8 4% 
Methicillin resistant Staphylococcus aureus 7 4% 
Enterococcus species 5 3% 
Methicillin sensitive Staphylococcus aureus 4 2% 
Klebsiella pneumoniae 4 2% 
Clostridium species 3 2% 
Methicillin sensitive Staphylococcus epidermidis 3 2% 
Propionibacterium species  3 2% 
Corynebacterium species 3 2% 
Streptococcus viridans 2 1% 
Acinetobacter species 2 1% 
Morganella morgagni 2 1% 
Escheria coli 2 1% 
Escheria coli ESBL+ 2 1% 
Propionibacterium acnes 2 1% 
Methicillin resistant coagulase - staphylococcus Species 1 1% 
Enterobacter cloacae 1 1% 
Streptococcus pyogenes 1 1% 
Serratia marcescens ESBL+ 1 1% 
Clostridium innocum 1 1% 
Serratia marcensens 1 1% 
Providentia sturartii ESBL+ 1 1% 
Sphingomonas paucimobilis 1 1% 
Candida species 1 1% 
Candida glabrata 1 1% 
Staphylococcus lugdudensis 1 1% 
Gram negative bacilli 1 1% 
Candida parapsilosis  6 3% 
Candida albicans 6 3% 
Toxoplasmosis IgG+  1 1% 
CMV IgG + 1 1% 
Values represent number and percentage of patients with each specific microorganism found on 
hemoculture. 
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Figure 1. Number of patients with sepsis during years evaluated 
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5. DISCUSSION 
 
 21 
 
Sepsis continuous to be a debilitating disease with high mortality (19,20,36). The 
incidence of sepsis appears to be increasing throughout the western world (19). The 
progressive ageing of the population is seen as one of the causes (19). 
In the general Intensive Care Unit at University Hospital of Split, the percentage of 
patients with sepsis were around 20% per year during the period of 2015 to the first quarter of 
2018. There is not a big difference seen between these years, and no big increase or decrease 
is seen from 2015 up to the first quarter of 2018. According to the SOAP study of sepsis in 
European intensive care units (20), the amount lies at 37.4%. 
The increase in mortality of patients with sepsis compared to those without sepsis is 
significantly higher, P < 0,001. This is consistent with what is seen in Intensive Care Units in 
the western world (19) and underlines the importance of early recognition and treatment of 
sepsis in patients before multiple organ dysfunction and resistance to therapy occurs.  
As the mortality of sepsis is so high in critically ill patients, it is important to further 
investigate what can be done to detect sepsis earlier to start antibacterial therapy as early as 
possible together with early resuscitation.  
There were no data taken on whether the patient had sepsis upon admission or later 
on. This could be a topic for further investigation to distinguish those patients who are 
admitted with sepsis and those that get sepsis at the department. There was also no checkup 
on patient mortality in those patients transferred to other departments or discharged, too see if 
there is also an increased rate of late mortality in patients with sepsis, who are later transferred 
to other departments.   
It is noticed that a high percentage of the septic patients went into septic shock and 
this could explain the high mortality rate as patients with septic shock show persistent 
hypotension resistant to vasopressor making resuscitation at this stage very hard and resulting 
with multiple organ dysfunctions (4,25-27). These patients are much harder to treat and so the 
importance of early treatment of sepsis is further emphasized by these results. 
Most patients diagnosed with sepsis had a confirmed infection on the hemoculture, 
according to the SOAP study of sepsis in European intensive care units, there were 60% 
confirmed hemoculture (20). This result is consistent with what was found at the UHS where 
the percentage of confirmed hemocultures were 76%. The negative cultures could be 
explained by the fact that hemoculture sampling not always is performed before introduction 
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of antimicrobial therapy, or those patients in whom a hemoculture was not performed, for 
example, in the patients who were deceased before hemoculture or any further treatment was 
started. 
The median age of patients with sepsis was 66 years (95% CI 63.0 to 67.8), while the 
median age of patients at the intensive care unit in the patients without sepsis was 63 years 
(95% CI 62 to 64). There is no significant difference between median age of the patient group 
with sepsis compared to the patient group without sepsis, P = 0,286 showing that in this case, 
age is not a risk factor for sepsis. This is within the same range as what is seen in intensive 
care units around Europe and the Western world (19).  
In this study it is also shown that the length of stay of patients with sepsis is 
significantly increased P < 0,001, from a median of 4 days to 11 days in the septic patients. 
This is an expected result, as patients with sepsis will have a worse general condition and are 
in need of more specialized care for a longer period of time. This is also seen in studies done 
in different countries throughout Europe where the length of stay in significantly increased 
(20,36-39). This is important to recognize as patients staying in the intensive care for a 
median of a week longer than the general patients is an important cost factor to recognize, as 
well as to recognize that these patients are severely ill for a longer time, which could also be 
discussed to contribute to the higher mortality rate as the state of these patients is worse for a 
longer period with a weaker chance of survival. 
The distribution in terms of gender shows that most patients in the intensive care unit 
are male, and so, also the distribution in terms of gender in the patient group with sepsis were 
mostly men, there was no significant difference in gender distribution between the groups of 
patients with sepsis and without sepsis, P = 0,346. This shows that gender is not a risk factor 
for sepsis at the University hospital of Split. The gender distribution at intensive care units are 
seen to be majorly male around Europe as well (1,15,19,36,40). 
In the hemocultures, 43% of the patients were found to have multiple 
microorganisms in the blood cultures. We did not study weather this affected the mortality, 
length of stay or any other factors. As no further data was gathered on the reason for 
admission of patients, whether they had sepsis upon admission or the origin of infection in 
patients with sepsis the question of why this could be cannot be answered within the scope of 
this paper. 
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The most prevalent microorganisms seen on the blood cultures were coagulase 
negative Staphylococcal species, seen in 28% of blood cultures, methicillin resistant 
Staphylococcus epidermidis is seen in 24% of hemocultures, Acinetobacter baumanii, seen in 
20% of blood cultures and Pseudomonas aeruginosa seen in 12% of blood cultures. Most of 
the other microorganisms are only seen a couple times. According to the SOAP study the 
most common microorganisms found in Europe were Staphylococcus aureus, including 
MRSA, Pseudomonas aeruginosa and Escheria coli (20). At the intensive care unit of 
University Hospital in Split, where the most common being Staphylococcus species but not 
specifically Staphylococcus aureus the prevalence of microorganisms are not too similar even 
though the most common microorganisms are seen here as well. Pseudomonas aeruginosa 
was seen in 12% of the blood cultures and thus is not one of the most common 
microorganisms and Escheria Coli was only seen in 2% of the blood cultures (Escheria Coli 
ESBL+ included), even though these seem to be more common around other hospitals in 
Europe (20). The difference in most prevalent microorganisms could be explained by the 
geographic differences. 
The second most common microorganism seen in the intensive care unit was 
methicillin resistant Staphylococcus epidermidis, 24%, which is commonly seen in Intensive 
Care Units. It can be discussed that the reason for this could be either human error when 
collecting the samples for blood culture, and thus having contaminated samples sent to the lab 
or that the sterility during different invasive procedures, such as insertion of venous catheter is 
not done properly. As there was no data gathered on which patients who were infected by 
which microorganisms and whether they are seen in the patients with sepsis upon admission 
or those who acquire sepsis at the department, no conclusion can be made on the reason for 
the high number of methicillin resistant Staphylococcus epidermidis. 
The third most prevalent bacteria is Acinetobacter baumanii, this is also consistent 
with nosocomial infections seen around the world, where Acinetobacter baumanii is seen to 
be increasing in the hospital milieu (41,42). 
A limitation of this study is that only one person was going through all paper files of 
patients, rendering this study quite susceptible to human error as over 1000 patient files was 
looked through. Furthermore, as this was a retrospective study, there was no way to gather 
information on any information that was missing from the files. 
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1. The incidence of sepsis at the general intensive care unit at the University hospital in 
Split was around 20% during the years 2015 to the first quarter of 2018. No great 
increase or decrease is seen during this period. 
2. Sepsis lead to a significant increase in mortality as well as length of stay in the 
patients at the general intensive care unit at the University hospital in Split.  
3. The mortality seen in the patient group with sepsis was 52% and the length of stay 11 
days (95% CI 9 to 13 days). 
4. There was no significant difference in age distribution and gender distribution between 
the patient group with sepsis and the patient group without sepsis. The median age of 
the patient group with sepsis was 66 years (95% CI 63 to 67.8) and most patients 
admitted to the department where male.  
5. Of the patients diagnosed with sepsis 76% had a confirmed blood culture and 43% of 
all septic patients were found to have multiple microorganismal infection.  
6. Of all the patients with sepsis 63% also went into septic shock during their stay at the 
intensive care unit.  
7. The most commonly seen bacteria in the hemocultures were coagulase negative 
Staphylococcal species, methicillin resistant Staphylococcus epidermidis and 
Acinetobacter baumanii.  
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Objectives: The aim of this paper is to learn more about the incidence of sepsis and septic 
shock at the general intensive care unit as well as looking into mortality, pathogen origin, age, 
gender and length of stay of the patients with sepsis and furthermore compare the results with 
the patient group who do not have sepsis.  
 
Materials and methods: The study is a retrospective study looking into patient records 
during the period between 2015 to the first quarter of 2018. Information about age, gender, 
length of stay and mortality was taken from all patients records during this period as well as 
blood cultures and whether the patients with sepsis also had septic shock. The statistical 
analyses were made using Medcalc. 
 
Results: Mortality was 52% in patients with sepsis, 43% of patients with sepsis had multiple 
microorganismal infection shown on blood culture. There was no significant difference 
between age and gender distribution in the patient group with sepsis and the patient group 
without. The most frequent bacteria seen in the blood cultures were coagulase negative 
staphylococcal species and methicillin resistant Staphylococcus epidermidis, of all the 
patients with sepsis 63% also had septic shock.  
 
Conclusion: Mortality was significantly increased in patients with sepsis compared to those 
who did not suffer from sepsis. The length of stay was significantly longer in patients with 
sepsis and patients stayed approximately a week longer in the intensive care unit when 
suffering from sepsis. The difference in age distribution and gender distribution was not 
significantly different in the patient group with sepsis compared to those patients who did not 
suffer from sepsis.  
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Naslov: SEPSA I SEPTIČKI ŠOK U JEDINICI INTENZIVNE NJEGE KLINIČKOG 
BOLNIČKOG CENTRA SPLIT, RETROSPEKTIVNA STUDIJA INCIDENCIJE, 
MORTALITETA I DUŽNI BORAVKA  
  
Ciljevi: Cilj ovog istraživanja su nova saznanja o incidenciji sepse i septičkog šoka u jedinici 
intenzivne njege, te usporedba mortaliteta, patologije, dobi, spola i duljine boravka kod 
pacijenata koji su imali sepsu i onih koji je nisu imali. 
 
Materijali i metode: Obuhvaća retrospektivni studij u kojoj su korišteni podaci pacijenata u 
periodu između 2015. do prve četvrtine 2018. godine. Korištene su informacije o dobi, spolu, 
dužini boravka, mortalitetu, nalazi hemokulture, te podatak koliko je pacijenata oboljelih od 
sepse imalo septički šok. Za statističku analizu korišten je Medcalc. 
 
Rezultati: Mortalitet pacijenata sa sepsom je 52%, kod njih 43% hemokulturom su izolirani 
multipli patogeni. Dokazano je da ne postoji značajna razlika između dobi i spola pacijenata 
koji su imali sepsu i oni koji je nisu imali. Najučestalija bakterija izolirana u hemokulturi je 
koagulaza negativni stafilokok i meticilin rezistentni Staphylococcus epidermidis, 63% 
pacijenata oboljelo od sepse je imalo septički šok. 
 
Zaključci: Mortalitet je značajno veći kod pacijenata oboljelih od sepse u usporedbi sa onima 
koji nisu oboljeli od iste. Duljina boravka je značajno duža kod pacijenata koji su imali sepsu, 
tjedan dana duže su boravili u jedinici intenzivne njege. Razlike u godinama i spolu nisu bile 
značajne medju pacijentima sa sepsom i onima koji je nisu imali.  
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